TP53 mutation was found in 27% of PDTCs and 42–63% of ATCs, which was considered a genetic hallmark of advanced thyroid tumors [4, 16, 20]. The gene discussed is TP53; the disease is Ehlers-Danlos syndrome, musculocontractural type.